Latest ATHE reports update at 2022-08-31: 2022 ∙ 2021 ∙ 2020

Alterity Therapeutics Limited ATHE

$ 2.0 -1.96%

Alterity Therapeutics Limited Balance Sheet 2011-2024 | ATHE

Annual Balance Sheet Alterity Therapeutics Limited

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-34.7 M	-28 M	-9.16 M	-14.4 M	-15.2 M	-21.9 M	-28.6 M	-34.9 M	-34.2 M	-12.5 M	-5.34 M	-8.55 M
Long Term Debt	59.9 K	37.9 K	868	-	-	-	-	-	-	-	-	-
Long Term Debt Current	57.6 K	27.7 K	32.9 K	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	73.6 K	47.7 K	-	35 K	916	440	470	2.41 K	3.03 K	133	6.94 K	4.39 K
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	5.89 M	3.12 M	2.76 M	3.36 M	2.64 M	1.59 M	2.36 M	2.72 M	3.95 M	3.1 M	1.72 M	2.08 M
Deferred Revenue	-	-	-	-	-	-	-	-	-	33.3 K	-	-
Retained Earnings	-182 M	-170 M	-154 M	-141 M	-130 M	-123 M	-125 M	-117 M	-111 M	-97.9 M	-90.1 M	-84.9 M
Total Assets	41.4 M	33.6 M	9.91 M	19.9 M	18.7 M	25.3 M	33.7 M	41.8 M	41.6 M	17.1 M	7.34 M	9.01 M
Cash and Cash Equivalents	34.8 M	28.1 M	9.2 M	14.4 M	15.2 M	21.9 M	28.6 M	-	-	-	-	-
Book Value	35.5 M	30.5 M	7.15 M	16.6 M	16.1 M	23.7 M	31.4 M	39.1 M	37.7 M	14 M	5.62 M	6.93 M
Total Shareholders Equity	35.5 M	30.5 M	7.15 M	16.6 M	16.1 M	23.7 M	31.4 M	-	-	-	-	-

All numbers in AUD currency

Quarterly Balance Sheet Alterity Therapeutics Limited

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	59.9 K	-	-	-	37.9 K	-	-	-	868	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	73.6 K	-	39.6 K	-	47.7 K	-	8.09 K	-	42.4 K	-	-	-	35 K	-	-	-	916	-	-	-	440	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	5.89 M	-	3.8 M	-	3.12 M	-	3.05 M	-	2.76 M	-	-	-	3.36 M	-	-	-	2.64 M	-	-	-	1.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-182 M	-	-176 M	-	-170 M	-	-163 M	-	-154 M	-	-147 M	-	-141 M	-	-	-	-130 M	-	-	-	-123 M	-	-	-	125 M	-	-	-	-117 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	41.4 M	-	44.9 M	-	33.6 M	-	37.4 M	-	9.91 M	-	-	-	19.9 M	-	-	-	18.7 M	-	-	-	25.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	34.8 M	-	37 M	-	28.1 M	-	35 M	-	9.2 M	-	12.2 M	-	14.4 M	-	-	-	15.2 M	-	-	-	21.9 M	-	-	-	28.6 M	-	-	-	34.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	35.5 M	-	41.1 M	-	30.5 M	-	34.4 M	-	7.15 M	-	-	-	16.6 M	-	-	-	16.1 M	-	-	-	23.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	35.5 M	-	41.1 M	-	30.5 M	-	34.4 M	-	7.15 M	-	11.2 M	-	16.6 M	-	-	-	16.1 M	-	-	-	23.7 M	-	-	-	31.4 M	-	-	-	39.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency